By analyzing ctDNA, we seek to elucidate whether the PIK3CA (H1047R) mutations can serve as reliable biomarkers for cancer detection and monitoring in dogs, thereby offering insights into the potential of liquid biopsy marker in CMTs. Here, PIK3CA is linked to cancer.